Life Science REIT PLC (LABS)

Category Property - Direct UK


Sell

37.80p

Buy

38.50p

arrow-down-0.20p (-0.52%)

Discount/Premium

-52.67%

Estimated NAV

80.716p

Prices updated at 19 Apr 2024, 17:24 BST
| Prices minimum 15 mins delay
|
Prices in GBX

Investment objective
The Company will seek to achieve its investment objective by investing in a diversified portfolio of properties across the UK which are typically leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. Life science is the branch of sciences concerned with the study of living organisms. This encompasses the study of the breadth of life processes, and the structure and behaviour of living things. Companies operating in the life science sector include, but are not limited to, those involved in the innovation, development and/or production of assets directly or indirectly for human health purposes.

arrow-up0.15%
LSE

38.20
Launch date19 Nov 2021
38.35p - 37.50p
77.40p - 37.10p
81.10 as of 31 Dec 2023
Ongoing charge audited (%)1.7
1.79
0.00
2.53
1,199,690.90
350.00m
133.00m
91.62
Semi-Annually
£282.51m
£276.15m
-35.30
-29.88
-
Fund comparative indexNo benchmark
SA
0.76m
0.46m
GB00BP5X4Q29
Please note that some funds may have small additional incidental charges that are not shown here. Where these charges do exist they are included within the variable ongoing costs in the Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.